MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

infusions

  • Mayo Study Finds Antibody Treatment Can Help COVID-19 Patients
    Mayo Study Finds Antibody Treatment Can Help COVID-19 Patients
    By Christopher Snowbeck From Star Tribune MINNEAPOLIS—A subset of COVID-19 patients who received infusions of laboratory-made antibodies ran a lower risk of requiring hospital care for their illnesses, according to ...
    September 1, 2021BY Tribune News Service
TOP NEWS
  • Trump on Iran Conflict: Troops Staying Until ‘We Have a Completion’
    NEW By T.J. Muscaro
    Trump on Iran Conflict: Troops Staying Until ‘We Have a Completion’
  • Israel Strikes Beirut Days After US-Supported Ceasefire Announcement
    3hr By Jack Phillips
    Israel Strikes Beirut Days After US-Supported Ceasefire Announcement
  • Former Utah Attorney General Fights the Evil That Lurks in Quiet Places
    3hr By Savannah Hulsey Pointer
    Former Utah Attorney General Fights the Evil That Lurks in Quiet Places
  • US Forces Shoot Down 2 Iranian Drones as Pakistani Interior Minister Visits Tehran
    5hr By Jacki Thrapp
    US Forces Shoot Down 2 Iranian Drones as Pakistani Interior Minister Visits Tehran
  • US Won’t Unfreeze Iran’s Assets Before Peace Deal Is Reached, Trump Says
    5hr By Jacki Thrapp
    US Won’t Unfreeze Iran’s Assets Before Peace Deal Is Reached, Trump Says
  • Fascia: The Living, Interconnected Web Behind Movement and Healing—How to Enhance Its Function
    6hr By Mercura Wang
    Fascia: The Living, Interconnected Web Behind Movement and Healing—How to Enhance Its Function
  • Eli Lilly Poised to Suspend Drug Discounts to Large Hospitals
    10hr By Lawrence Wilson
    Eli Lilly Poised to Suspend Drug Discounts to Large Hospitals
  • US Bankruptcy Filings Increase 7 Percent Yearly
    11hr By Naveen Athrappully
    US Bankruptcy Filings Increase 7 Percent Yearly
  • How a Tiny Insect Decimated Florida’s Citrus, and What Orchardists Are Doing About It
    12hr By Jacob Burg
    How a Tiny Insect Decimated Florida’s Citrus, and What Orchardists Are Doing About It
  • Treasury Department Seeks to Redirect Iranian Assets to Gulf Nations for War Damages
    17hr By Melanie Sun
    Treasury Department Seeks to Redirect Iranian Assets to Gulf Nations for War Damages
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top